139 related articles for article (PubMed ID: 31402218)
21. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.
Gao Y; Zhao H; Lu Y; Li H; Yan G
Tumour Biol; 2014 Nov; 35(11):11041-50. PubMed ID: 25095976
[TBL] [Abstract][Full Text] [Related]
23. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
26. Genetic Analysis Reveals the Important Role of the
Lai YC; Wang WC
Anticancer Res; 2021 Sep; 41(9):4295-4304. PubMed ID: 34475049
[TBL] [Abstract][Full Text] [Related]
27. Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review.
Khene ZE; Kammerer-Jacquet SF; Bigot P; Rabilloud N; Albiges L; Margulis V; De Crevoisier R; Acosta O; Rioux-Leclercq N; Lotan Y; Rouprêt M; Bensalah K
Eur Urol Oncol; 2024 Jun; 7(3):401-411. PubMed ID: 37925349
[TBL] [Abstract][Full Text] [Related]
28. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract][Full Text] [Related]
29. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
30. Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis.
Yu GS; Lai CY; Xu Y; Bu CF; Su ZX
Asian Pac J Cancer Prev; 2015; 16(11):4665-9. PubMed ID: 26107221
[TBL] [Abstract][Full Text] [Related]
31. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
32. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.
Hauser S; Zahalka T; Fechner G; Müller SC; Ellinger J
Anticancer Res; 2013 Oct; 33(10):4651-6. PubMed ID: 24123044
[TBL] [Abstract][Full Text] [Related]
33. Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.
Deckers IA; van Engeland M; van den Brandt PA; Van Neste L; Soetekouw PM; Aarts MJ; Baldewijns MM; Keszei AP; Schouten LJ
Int J Epidemiol; 2017 Apr; 46(2):622-631. PubMed ID: 27789672
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide promoter methylome of small renal masses.
Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
[TBL] [Abstract][Full Text] [Related]
35. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
36. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract][Full Text] [Related]
37. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
[TBL] [Abstract][Full Text] [Related]
38. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
Diana P; Klatte T; Amparore D; Bertolo R; Carbonara U; Erdem S; Ingels A; Kara O; Marandino L; Marchioni M; Muselaers S; Pavan N; Pecoraro A; Pecoraro A; Roussel E; Campi R;
World J Urol; 2023 Apr; 41(4):929-940. PubMed ID: 35362747
[TBL] [Abstract][Full Text] [Related]
39. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
40. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.
Gu Y; Zou YM; Lei D; Huang Y; Li W; Mo Z; Hu Y
Sci Rep; 2017 Oct; 7(1):14200. PubMed ID: 29079774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
